EB
Enveric Biosciences Inc
🇺🇸XNAS.ENVBUnited StatesHealthcare
$1.49USDup +0.01 (+0.68%)Pre-marketDelayed1:29 PM
Price$1.49+0.01 (+0.68%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US29405E1091
- CUSIP
- 29405E109
Company
- Employees
- 5
- Headquarters
- Cambridge, United States
- Website
- https://www.enveric.com
- CEO
- Dr. Joseph Edward Tucker Ph.D.
Market
- Shares outstanding
- 4.5M
- Market cap
- $6.67M
Highlights
- Market cap
- $6.67M
- EPS LTM
- -$2.19
- P/E LTM
- -0.63
- Div yield
- 60.62%
Fundamentals (LTM)
- Revenue
- $0-100%down year on year
- Net income
- -$8.73M+12.21%up year on year
- Gross margin
- Not reported
- Free cash flow
- -$8.56M-31.3%down year on year
Other listings
This company is not listed on any other exchange we cover.
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.